Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects
Clinical trial NCT04505436 · COMPLETED
Trial details
- NCT number
- NCT04505436
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-31
- Primary completion
- 2026-06-26
- Enrollment
- 215
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.